Compare Barclays PLC (BCS) vs UnitedHealth Group Inc (UNH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Barclays PLC vs UnitedHealth Group Inc — how do they compare? Barclays PLC trades at $28.06 (market cap $93.87B), while UnitedHealth Group Inc trades at $404.96 (market cap $361.00B). The key difference: UnitedHealth Group Inc is far larger — about 3.8× Barclays PLC's market cap, and UnitedHealth Group Inc pays the higher dividend (2.31%). Which is the better fit depends on your goals.
| BCS | UNH | |
|---|---|---|
Market Cap | $93.87B | $361.00B |
Sector | Financials | Health |
52-Week High | $28.56 | $436.35 |
52-Week Low | $19.36 | $259.02 |
Dividend Yield | 2.19% | 2.31% |
Enterprise Value | — | $402.86B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Barclays PLC (BCS) trades at $28.08, up 0.36% today, with a bullish technical signal from moving averages and a P/B ratio below 1 at 0.88, indicating potential undervaluation. Recent earnings have consistently beaten expectations, with Q2 2026 EPS of $0.90 surpassing the $0.89 estimate, while revenue growth accelerated to $29.14 billion in 2025. However, the stock faces headwinds from a securities class action investigation and concerns over cost pressures highlighted in recent analyst reports.
The outlook for BCS is cautiously optimistic, supported by strong profitability with a net income margin of 25.51% and analyst consensus favoring Buy ratings (68%). Key risks include ongoing legal scrutiny and rising operating expenses, but the stock's low valuation and dividend yield near 1.1% offer value for long-term investors amid stable cash flow trends.
UnitedHealth Group (UNH) trades at $408.74, showing modest daily gains of 0.41% amid a bearish technical signal. The company demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust analyst support (82.7% buy ratings). Recent developments include dividend payments and strategic initiatives to streamline pediatric care authorizations, positioning UNH well in the healthcare sector.
UNH presents a compelling investment case with strong cash flow generation and market leadership, though investors face risks from regulatory scrutiny and margin compression. The stock trades at a discount to analyst consensus target of $476.50, offering potential upside if operational improvements and growth initiatives materialize as projected.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Barclays PLC
Barclays is a universal bank headquartered in the United Kingdom. It operates via two principal segments
Read more on BCS →About UnitedHealth Group Inc
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →
